Healthcare IPOs » By The Online Investor Staff, updated Mon., Jul. 6, 10:25 PM
Recent initial public offerings in the Healthcare IPOs category.
Slide #1. Obalon Therapeutics, Inc. — Initial Public Offering
| Company: |
Obalon Therapeutics, Inc. |
| Proposed Symbol: |
OBLN |
| Shares Offered: |
5,000,000 |
| Price Per Share: |
$15.00 |
| Over-Allotment: |
750,000 |
| Description: |
Obalon Therapeutics, Inc., a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $15.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on October 6, 2016 under the symbol "OBLN." In addition, the underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of common stock. |
IPOs: Obalon Therapeutics, Inc.
List of Healthcare IPOs in this Slideshow:
Company Ticker IPO Date
Concert Pharmaceuticals CNCE
Akebia Therapeutics AKBA
Recro Pharma, Inc. REPH
Phibro Animal Health Corporation PAHC
Galmed Pharmaceuticals GLMD
Agile Therapeutics, Inc. AGRX
MediWound Ltd MDWD
SCYNEXIS SCYX
Applied Genetic Technologies CorporationAGTC
Phibro Animal Health Corporation PAHC
Adamas Pharmaceuticals, Inc. ADMS
Quotient Limited QTNT
Aldeyra Therapeutics ALDX
Pfenex Inc PFNX 7/24/2014
Radius Health, Inc. RDUS
Zosano Pharma Corporation ZSAN
Lantheus Holdings, Inc. LNTH
Amphastar Pharmaceuticals, Inc. AMPH
Adeptus Health, Inc. ADPT
Karyopharm Therapeutics Inc. KPTI
Affimed AFMD
Minerva Neurosciences, Inc. NERV
ReWalk Robotics Ltd. RWLK
IRadimed Corporation IRMD
SAGE Therapeutics, Inc SAGE
Auris Medical Holding AG EARS
Intersect ENT, Inc. XENT 7/24/2014
Ocular Therapeutix OCUL
ContraFect Corporation CFRX
VBL Therapeutics VBLT
Catalent, Inc. CTLT
Marinus Pharmaceuticals, Inc. MRNS
T2 Biosystems, Inc. TTOO
Cellectar Biosciences, Inc. CLRB
ProQR Therapeutics PRQR
Forward Pharma A/S FWP
Calithera Biosciences, Inc. CALA
Atara Biotherapeutics, Inc. ATRA
Xenon Pharmaceuticals Inc. XENE
Nevro NVRO
Coherus BioSciences, Inc. CHRS
Bellicum Pharmaceuticals, Inc. BLCM
Second Sight Medical Products, Inc. EYES
Check-Cap Ltd. CHEK 2/19/2015
Invitae Corporation NVTA
Zosano Pharma Corporation ZSAN
Ascendis Pharma A/S ASND
Bellerophon Therapeutics BLPH
OpGen OPGN
Summit Therapeutics plc SMMT
Blueprint Medicines Corporation BPMC
Cellectis CLLS
aTyr Pharma, Inc. LIFE
Xbiotech XBIT
Cidara Therapeutics, Inc. CDTX
Viking Therapeutics, Inc. VKTX
HTG Molecular Diagnostics HTGM
Adaptimmune Therapeutics plc ADAP
Collegium Pharmaceutical, Inc. COLL
Glaukos Corporation GKOS
Teladoc TDOC
Glaukos Corporation GKOS
Catabasis Pharmaceuticals CATB
Seres Therapeutics, Inc. MCRB
Neos Therapeutics, Inc. NEOS
NantKwest, Inc. NK
vTv Therapeutics Inc. VTVT
Intec Pharma Ltd. NTEC
Zynerba Pharmaceuticals, Inc. ZYNE
Aimmune Therapeutics, Inc. AIMT
Benitec Biopharma Limited BNTC
REGENXBIO Inc. RGNX
Penumbra, Inc. PEN
Nabriva Therapeutics AG NBRV
NovoCure Limited NVCR
Aclaris Therapeutics, Inc. ACRS
CytomX Therapeutics, Inc. CTMX
MyoKardia, Inc. MYOK
WAVE Life Sciences Ltd. WVE
Mesoblast Limited MESO
Kitov Pharmaceuticals Holdings Ltd. KTOV
BeiGene, Ltd. BGNE
Editas Medicine, Inc. EDIT
Proteostasis Therapeutics, Inc. PTI
Syndax Pharmaceuticals, Inc. SNDX
Corvus Pharmaceuticals, Inc. CRVS
Aeglea BioTherapeutics, Inc. AGLE
Intellia Therapeutics, Inc. NTLA
Spring Bank Pharmaceuticals, Inc. SBPH
Pulse Biosciences, Inc. PLSE
Merus B.V. MRUS
Reata Pharmaceuticals, Inc. RETA
Clearside Biomedical, Inc. CLSD
Selecta Biosciences, Inc. SELB
Syros Pharmaceuticals SYRS
Kadmon Holdings, Inc. KDMN
Tactile Systems Technology, Inc. TCMD
Cellect Biotechnology Ltd. APOP
Fulgent Genetics FLGT
Obalon Therapeutics, Inc. OBLN
